Ashanti Epperson is a Dallas, Georgia based female eyecare provider who is specialized as Optician. Active license number of Ashanti Epperson is LDO002644 for Optician in Georgia. Ashanti Epperson makes / sells eyeglasses and, contact lenses, for remedying defects of vision in accordance with the prescriptions of ophthalmologists and optometrists. Opticians also specializes in filling lens prescriptions, assisting patients with lens and frame selection and fitting (including style, weight and colour) but they do not test vision or write prescriptions for visual correction.
Complete Profile:
Ashanti Epperson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Optician
Gender:
Female
Practice Address:
232 Silver Fox Trl, Dallas, Georgia, 30157-8282
Phone:
470-785-3145
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1689355810
NPI Enumeration Date:
31 Jul, 2023
NPI Last Update On:
31 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ashanti Epperson are as mentioned below.
License Number
Specialization
State
Status
LDO002644
Optician
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5830 E 2nd St Ste 70009303, Casper, Wyoming
Zip:
82609-4308
Phone Number:
--
Fax Number:
--
Patients can reach Ashanti Epperson at 232 Silver Fox Trl, Dallas, Georgia or can call to book an appointment on 470-785-3145. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.